Aspiriant LLC’s T-Mobile US TMUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$272K Sell
1,294
-400
-24% -$82.2K 0.01% 293
2025
Q4
$344K Buy
1,694
+210
+14% +$44.5K 0.01% 257
2025
Q3
$355K Sell
1,484
-183
-11% -$44.3K 0.01% 229
2025
Q2
$397K Buy
1,667
+215
+15% +$52.5K 0.01% 226
2025
Q1
$387K Sell
1,452
-448
-24% -$110K 0.01% 211
2024
Q4
$419K Buy
1,900
+322
+20% +$73.2K 0.02% 206
2024
Q3
$326K Sell
1,578
-71
-4% -$13.6K 0.01% 225
2024
Q2
$291K Sell
1,649
-83
-5% -$13.9K 0.01% 234
2024
Q1
$283K Sell
1,732
-33
-2% -$5.37K 0.01% 254
2023
Q4
$283K Buy
1,765
+10
+0.6% +$1.48K 0.01% 252
2023
Q3
$246K Buy
+1,755
New +$243K 0.01% 250

Other funds holding TMUS

Aspiriant LLC's TMUS Position: Q1 2026 in Review

Aspiriant LLC reduced its T-Mobile US (TMUS) stake by 24% in Q1 2026, selling an estimated $82.2K and leaving 1,294 shares worth $272K. The position accounts for 0.01% of the portfolio, ranked #293.

Aspiriant LLC first reported a position in TMUS in Q3 2023 and has held it in 11 quarters since. The position peaked at $419K in Q4 2024. 1,719 funds tracked by Wall St. Rank hold TMUS as of Q1 2026.

  • Aspiriant LLC held 1,294 shares of T-Mobile US worth $272K as of Q1 2026.
  • Aspiriant LLC sold 400 T-Mobile US shares in Q1 2026, an estimated $82.2K.
  • T-Mobile US made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #293 holding.
  • Aspiriant LLC first reported a position in T-Mobile US in Q3 2023 and has held it in 11 quarters since.
  • Aspiriant LLC's T-Mobile US position peaked at $419K in Q4 2024.
  • 1,719 funds tracked by Wall St. Rank held T-Mobile US as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.